Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study
Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study have?
Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study has 132 citations in the OpenAlex counts ScholarIQ stores.
When was Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study published?
Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study has 2017 year in the ScholarIQ index.
What is the open-access status of Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study?
Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study has hybrid oa status in the ScholarIQ index.
What is the DOI of Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study?
The DOI for Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study is on the source record.
What is the PMID of Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study?
The PMID for Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study is on the source record.
What is the OpenAlex record for Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study?
The OpenAlex for Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study is on the source record.